Atara Biotherapeutics Inc
NASDAQ:ATRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
Airbus SE
F:AIRA
|
NL |
|
Dhani Services Ltd
BSE:532960
|
IN |
|
Mediobanca Banca di Credito Finanziario SpA
MIL:MB
|
IT |
|
Carmila SA
PAR:CARM
|
FR |
|
A
|
ALT Telecom PCL
SET:ALT
|
TH |
|
S
|
SM Culture & Contents Co Ltd
KOSDAQ:048550
|
KR |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
OTC:AIQUF
|
FR |
|
Applyflow Ltd
ASX:AFW
|
AU |
|
Pioneer Power Solutions Inc
NASDAQ:PPSI
|
US |
|
P
|
Pearson PLC
XBER:PES
|
UK |
|
Alfen NV
OTC:ALFNF
|
NL |
|
A
|
American Electric Power Company Inc
XHAM:AEP
|
US |
|
Eos Energy Enterprises Inc
NASDAQ:EOSE
|
US |
|
Amerigo Resources Ltd
TSX:ARG
|
CA |
|
V
|
Volkswagen AG
XHAM:VOW3
|
DE |
|
Nikola Corp
NASDAQ:NKLA
|
US |
|
M
|
MC Mining Ltd
ASX:MCM
|
AU |
|
G
|
Global Green Chemicals PCL
SET:GGC
|
TH |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
Morgan Stanley
NYSE:MS
|
US |
Bankruptcy Probability
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Atara Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
80.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Atara Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Atara Biotherapeutics Inc has total debt of 32.7m USD. This includes both short-term (0 USD) and long-term (32.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
